15 Apr 2021
Johnson & Johnson: Continue to believe in positive benefit-risk profile of COVID-19 vaccine
“We continue to believe in a positive benefit-risk profile of COVID-19 vaccine,” Johnson & Johnson said in response to the statement released after the US CDC Advisory Committee meeting.
more to come ....